BioMed X is an independent research institute with locations in Heidelberg, Germany, New Haven, and an open innovation incubator at Boehringer Ingelheim’s R&D campus in Ridgefield, Connecticut, along with a global partner network.
At the intersection of academia and industry, we drive pioneering research in oncology, immunology, neuroscience, platform technologies, and artificial intelligence.
Supported by leading pharmaceutical companies, our projects are led by early-career scientists recruited from top institutions worldwide. Through global crowdsourcing and local incubation, we tackle major biomedical R&D challenges.
With a focus on curiosity-driven exploration and rigorous validation, we advance translational biomedicine and foster cross-disciplinary innovation. Our research has also resulted in the development of new technologies for the pharmaceutical and biotech industries, such as T-FINDER.
We stand for free, creative, and curiosity-driven research combined with a solid validation of results, timelines, and deliverables. We serve a large purpose in advancing translational biomedicine by leveraging synergies and fostering cross-pollination across disciplines.
